Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled study of laquinimod in active lupus nephritis
2010-018329-20Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of laquinimod in lupus nephritis (LN) (3 arms), sponsored by Teva Pharmaceutical Industries Ltd. Started Feb 2010; status: completed.
02
Drugs
laquinimod
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on 2010-018329-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018329-20.